BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27544696)

  • 1. Psychoactive substance use prior to the development of iatrogenic opioid abuse: A descriptive analysis of treatment-seeking opioid abusers.
    Cicero TJ; Ellis MS; Kasper ZA
    Addict Behav; 2017 Feb; 65():242-244. PubMed ID: 27544696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of female patients seeking in-patient treatment for prescription opioid abuse from a tertiary care drug dependence treatment centre from India.
    Dayal P; Balhara YP
    Indian J Med Res; 2016 Jan; 143(1):95-100. PubMed ID: 26997020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the demand side of the prescription opioid epidemic: Does the initial source of opioids matter?
    Cicero TJ; Ellis MS
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S4-S10. PubMed ID: 28363319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sources of prescription opioids among diagnosed opioid abusers.
    Shei A; Rice JB; Kirson NY; Bodnar K; Birnbaum HG; Holly P; Ben-Joseph R
    Curr Med Res Opin; 2015 Apr; 31(4):779-84. PubMed ID: 25661018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse.
    Cicero TJ; Lynskey M; Todorov A; Inciardi JA; Surratt HL
    Pain; 2008 Sep; 139(1):127-135. PubMed ID: 18455314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency Department Prescription Opioids as an Initial Exposure Preceding Addiction.
    Butler MM; Ancona RM; Beauchamp GA; Yamin CK; Winstanley EL; Hart KW; Ruffner AH; Ryan SW; Ryan RJ; Lindsell CJ; Lyons MS
    Ann Emerg Med; 2016 Aug; 68(2):202-8. PubMed ID: 26875061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The iatrogenic epidemic of prescription drug abuse: county-level determinants of opioid availability and abuse.
    Wright ER; Kooreman HE; Greene MS; Chambers RA; Banerjee A; Wilson J
    Drug Alcohol Depend; 2014 May; 138():209-15. PubMed ID: 24679840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin.
    Pergolizzi JV; LeQuang JA; Taylor R; Raffa RB;
    Postgrad Med; 2018 Jan; 130(1):1-8. PubMed ID: 29190175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem?
    Kanayama G; Cohane GH; Weiss RD; Pope HG
    J Clin Psychiatry; 2003 Feb; 64(2):156-60. PubMed ID: 12633124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
    Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
    Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine.
    Mendelson J; Flower K; Pletcher MJ; Galloway GP
    Exp Clin Psychopharmacol; 2008 Oct; 16(5):435-41. PubMed ID: 18837640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.
    Peacock A; Bruno R; Cama E; Kihas I; Larance B; Lintzeris N; Hordern A; White N; Ali R; Degenhardt L
    Drug Alcohol Rev; 2015 Nov; 34(6):611-22. PubMed ID: 26084592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective evaluation of psychotherapeutic and illicit drug use in patients presenting with chronic pain at the time of initial evaluation.
    Manchikanti L; Cash KA; Malla Y; Pampati V; Fellows B
    Pain Physician; 2013 Jan; 16(1):E1-E13. PubMed ID: 23340539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France.
    Pauly V; Pradel V; Pourcel L; Nordmann S; Frauger E; Lapeyre-Mestre M; Micallef J; Thirion X
    Drug Alcohol Depend; 2012 Nov; 126(1-2):13-20. PubMed ID: 22475815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Kentucky's Comprehensive Opioid Legislation on Patients Presenting with Prescription Opioid or Heroin Abuse to One Urban Emergency Department.
    Faryar KA; Freeman CL; Persaud AK; Furmanek SP; Guinn BE; Mattingly WA; Wiemken TL; Buckner KA; Huecker MR
    J Emerg Med; 2017 Dec; 53(6):805-814. PubMed ID: 29102093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment.
    Inciardi JA; Surratt HL; Cicero TJ; Beard RA
    Pain Med; 2009 Apr; 10(3):537-48. PubMed ID: 19416440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.